Neurology CCM Automation FAQ | AI Solutions for Brain Health

Automated outreach prompts patients or families to log seizure activity and medication compliance, providing the epileptologist with a structured longitudinal data set. This is significantly more accurate than retrospective recall during a visit, leading to better-informed clinical decisions.

The system schedules check-ins around infusion or injection cycles to monitor for infusion reactions or side effects. This ensures that MS patients remain adherent to their long-term DMT regimens and that any adverse events are captured and addressed by the clinical team immediately.

Tile Healthcare's AI uses natural language processing to detect red flags, such as sudden gait changes, increased confusion, or new focal deficits. It immediately escalates the call to a clinical staff member for urgent intervention, preventing unnecessary ER visits.

Every interaction is transcribed and summarized with specific CPT-compliant data points, including time spent and clinical observations. This ensures your neurology practice has a robust, searchable audit trail for 99490 or APCM billing, maximizing reimbursement safety.

Our platform is designed to interface with major EHR systems used in neurology, such as Epic, Athenahealth, and eClinicalWorks. It pushes structured data and call summaries directly into the patient's neurological record, maintaining a single source of truth for the care team.

It acts as a force multiplier rather than a replacement. Instead of a nurse spending hours on manual outreach and voicemail tags, the AI handles 80% of routine data collection. This allows your nurse to focus only on patients requiring clinical judgment and complex care coordination.

Automated pathways monitor for secondary prevention compliance, such as blood pressure control and antiplatelet adherence. It also screens for post-stroke depression or cognitive changes, ensuring that stroke survivors receive the necessary rehabilitative support during the critical first 90 days.

The AI uses standardized pain scales to monitor peripheral neuropathy progression. It alerts the practice if a patient's mobility is impacted or if their current neuropathic pain management is failing, allowing for timely adjustments to Gabapentin or other therapies.

Yes, for adolescent epilepsy or neurodevelopmental clinics, the AI manages the transition of care communication between parents and the clinical team. This ensures continuity of care and medication adherence as the patient matures and moves toward adult neurology services.